tranylcypromine sulfate
tranylcypromine sulfate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Tranylcypromine Sulfate, PARNATE, TRANYLCYPROMINE SULFATE. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- tranylcypromine sulfate
- Brand Names
- Tranylcypromine Sulfate, PARNATE, TRANYLCYPROMINE SULFATE
- Application Number
- NDA012342
- Sponsor
- Actavis Pharma, Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- TRANYLCYPROMINE SULFATE
Indications and Usage
1 INDICATIONS AND USAGE PARNATE is indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants. PARNATE is not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions [ see Contraindications (4) , Warnings and Precautions (5) , and Drug Interactions (7) ] . PARNATE is a monoamine oxidase inhibitor (MAOI) indicated for the treatment of major depressive disorder (MDD) in adult patients who have not responded adequately to other antidepressants (1) PARNATE is not indicated for the initial treatment of MDD due to the potential for serious adverse reactions and drug interactions, and the need for dietary restrictions ( 1 , 4 , 5 , 7 )